HUMASCEND
DEAD

Serial Number

90669881

Owner

Bausch Health Ireland Limited

Attorney

Jeremy Blackowicz

Filing Date

Apr 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HUMASCEND Trademark

Serial Number: 90669881

HUMASCEND is a trademark filed by Bausch Health Ireland Limited on April 25, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Bausch Health Ireland Limited (2 trademarks)

3013 Lake Drive Citywest Business Campus

Entity Type: 99

Trademark Details

Filing Date

April 25, 2021

Registration Date

Not Registered

Published for Opposition

August 16, 2022

Goods & Services

Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devices, namely, medical instruments designed for the non-invasive removal of human body fat using an external energy source

Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucousitis and bone and soft tissue regeneration; Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis; Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures; Pharmaceutical preparations and substances to prevent and treat epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases such as Wilson and Huntington's disease, cardiovascular/angina, hyperammonaemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract, lungs, heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections; Vitamins and mineral supplements; none of the aforementioned goods relating to treatment or prevention of diabetes

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 11, 2026 ASCK
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 11, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 11, 2023 ABN6
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 8, 2023 ASCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 7, 2023 NOAM
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 18, 2023 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 28, 2022 ASCK
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 25, 2022 ETOP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 14, 2022 ASCK
POST PUBLICATION AMENDMENT - ENTERED
Oct 28, 2022 CHPB
ASSIGNED TO PETITION STAFF
Oct 24, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 5, 2022 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 25, 2022 ETOF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2022 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 16, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jul 12, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 8, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 5, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 5, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 5, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 5, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 5, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 16, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2021 NWOS
NEW APPLICATION ENTERED
Apr 28, 2021 NWAP